sulfur or nitrogen atom substitutions of single oxygen atoms
often exhibit rescue behavior by “soft” metal ions,3 thereby
implicating the substituted oxygen atom as a metal ligand.
However, the small number of nucleoside analogues currently
available5 limits the scope and applicability of these metal
ion rescue experiments.
We previously conducted metal ion rescue experiments
together with quantitative analysis to study the exon-ligation
step of group II intron self-splicing.3g,h,o Using 2′-amino-
uridine and 3′-thiouridine, we obtained evidence that both
the 2′- and 3′-oxygen atoms at the cleavage site (U877 at the
3′-terminus of the ai5γ group II intron) coordinate divalent
metal ions in the transition state3g (Figure 1). However,
(or 3′)-amino7 (or thio8) single-modified uridines and 2′,3′-
doubly modified nucleosides such as 2′,3′-dideoxy-2′,3′-
diamino-,9 2′,3′-dideoxy-2′,3′-dithio-,10 and 2′-deoxy-2′-thio-
3′-deoxy-3′-aminouridines11 have been reported, the 2′,3′-
dideoxy-2′-amino-3′-thio nucleosides remain unknown. Here,
we describe a convenient synthesis of the uridine analogue.
Our synthesis of 2′,3′-dideoxy-2′-amino-3′-thiouridine 12
begins with the commercially available 2,2′-anhydrouridine
1 (Scheme 1). We used the method of McGee et al. to prepare
2′-deoxy-2′-amino-5′-O-(4,4′-dimethoxy-trityl)uridine (2).12
Successive mesylation/displacement reactions have enabled
installation of a 3′-R-sulfur atom into uridine previously.13
To employ this strategy in our synthesis, the amino group
of 2 must bear a protecting group that fulfills several
criteria: (1) it must weaken the nucleophilicity of the 2′
amine so as to allow selective mesylation of the 3′-R
hydroxyl group, (2) it must remain unaffected under strongly
basic conditions (1-6 N NaOH in ethanol) used for
displacement of the 3′-R mesylate, and (3) it must undergo
facile removal under appropriate conditions. Based on these
considerations, we chose tert-butoxycarbonyl (Boc), well-
known for its use in peptide chemistry but used infrequently
in nucleic acid chemistry. To obtain the Boc-protected
nucleoside, 2′-deoxy-2′-amino-5′-O-(4,4′-dimethoxytrityl)-
uridine (2) was treated at 40 °C overnight with 2-(tert-
butoxycarbonyloxyimino)-2-phenylacetonitrile (Boc-ON)14 in
dioxane to afford 3 selectively in 94% yield. Other reagents,
such as di-tert-butyl dicarbonate,15 or other solvents, such
as methanol (MeOH) or acetonitrile (CH3CN), gave 3 in
significantly lower yields.
Figure 1. Metal ion ligands in the transition state for the exon
ligation step of group II intron self-splicing. R1 and R2 are exon 1
and exon 2, respectively. The 3′-hydroxyl group of exon 1 (OR1)
attacks the 5′-splice site, giving rise to spliced exons and releasing
the excised intron. Both the 2′- and 3′-oxygen atoms of the cleavage
site uridine interact with metal ions,3g,h,o but it remains unknown
whether two metal ions (as in A) or a single metal ion (as in B)
mediate(s) these interactions. Dots symbolize metal ion coordina-
tion.
To test whether the Boc group meets the aforementioned
requirements, we conducted the following control experi-
ments: (i) 3 was treated with methanesulfonyl chloride in
pyridine to generate compound 4a selectively in 90% yield.16
We could detect no mesylation of the 2′-NHBoc group under
these conditions. (ii) Overnight treatment of compound 3 with
6 N NaOH in ethanol (1:2 v/v) at room temperature gave
no reaction, suggesting that the Boc group would remain
whether two distinct metal ions mediate these interactions
(Figure 1A) or a single metal ion mediates both interactions
(Figure 1B) remains unknown. Metal ion rescue experiments
using an oligonucleotide substrate containing doubly modi-
fied 2′,3′-dideoxy-2′-amino-3′-thiouridine residue at the
cleavage site could help to answer this fundamental mecha-
nistic question.6 Preparation of such a substrate requires
synthesis of the parent nucleoside 12 and its incorporation
into an oligonucleotide. Although numerous syntheses of 2′
(7) (a) McGee, D. P. C.; Sebesta, D. P.; O’Rourke, S. S.; Martinez, R.
L.; Jung, M. E.; Pieken, W. A. Tetrahedron Lett. 1996, 37, 1995-1998.
(b) Holletz, T.; Cech, D. Synthesis 1994, 789-791. (c) Tong, W.; Xi, Z.;
Gioeli, C.; Chattopadhyaya, J. Tetrahedron 1991, 47, 3431-3450.
(8) (a) Elzagheid, M.; Azhayev, A.; Oivanen, M.; Lonnberg, H. Collect.
Czech. Chem. Commun. 1996, 61 (Special Issue), S42-S44. (b) Johnson,
R.; Reese, C. B.; Zhang, P. Tetrahedron 1995, 51, 5093-5098.
(9) Sasaki, T.; Minamoto, K.; Sugiura, T.; Niwa, M. J. Org. Chem. 1976,
41, 3138-3143.
(10) Johnson, R.; Joshi, B. V.; Reese, C. B. J. Chem. Soc., Chem.
Commun. 1994, 133-134.
(11) Sekiya, T.; Ukita, T. Chem. Pharm. Bull. 1967, 15, 1053-1057.
(12) McGee, D. P. C.; Vaughn-Settle, A.; Vargeese, C.; Zhai, Y. J. Org.
Chem. 1996, 61, 781-785.
(13) (a) Specht, A.; Loudwig, S.; Peng, L.; Goeldner, M. Tetrahedron
Lett. 2002, 43, 8947-8950. (b) Belostotskii, A. M.; Keren-Yeshuah, H.;
Lexner, J.; Hassner, A. Nucleosides, Nucleotides Nucleic Acids 2001, 20,
93-101. (c) Liu, X.; Reese, C. B. J. Chem. Soc., Perkin Trans. 1 2000,
2227-2236. (d) Cosstick, R.; Vyle, J. S. J. Chem. Soc., Chem. Commun.
1988, 15, 992-993.
(14) Cohen, G. M.; Cullis, P. M.; Hartley, J. A.; Mather, A.; Symons,
M. C. R.; Wheelhouse, R. T. J. Chem. Soc., Chem. Commun.1992, 298-
300.
(15) Tarbell, D. S.; Yamamoto, Y.; Pope, B. M. Proc. Natl. Acad. Sci.
U.S.A. 1972, 69, 730-732.
(16) Reddy, P.; Mallikarjuna; B.; Thomas, C. Bioorg. Med. Chem. Lett.
2003, 13, 1281-1285.
(4) (a) Sigel, R. K. O.; Song, B.; Sigel. H. J. Am. Chem. Soc. 1997, 119,
9, 744-755. (b) Pecoraro, V. L.; Hermes, J. D.; Cleland, W. W.
Biochemistry 1984, 23, 5262-71. (c) Jaffe, E. K.; Cohn, M. J. Boil. Chem.
1978, 253, 4823-4825.
(5) (a) Sabbagh, G.; Fettes, K. J.; Gosain, R.; O’Neil, I. A.; Cosstick, R.
Nucleic Acids Res. 2004, 32, 495-501. (b) Schwans, J. P., Cortez, C. N.,
Olvera, J. M.; Piccirilli, J. A. J. Am. Chem. Soc. 2003, 125, 10012-10018.
(c) Fettes, K. J.; O’Neil, I. A.; Roberts, S. M.; Cosstick, R. Nucleosides,
Nucleotides Nucleic Acids 2001, 20, 1351-1354. (d) Hamm, M. L.;
Piccirilli, J. A. J. Org. Chem. 1999, 64, 5700-5704. (e) Hamm, M. L.;
Piccirilli, J. A. J. Org. Chem. 1997, 62, 2, 3415-3420. (f) Sun, S.; Yoshida,
A.; Piccirilli, J. A. RNA 1997, 3, 1352-1363. (g) Cosstick, R.; Vyle, J. S.
Nucleic Acids Res. 1990, 18, 829-835.
(6) Quantitative enzymatic analyses using substrates containing multiple
modifications have advanced our understanding of the Tetrahymena
ribozyme reaction.3d,i,n,p
2170
Org. Lett., Vol. 6, No. 13, 2004